Biden Administration Rescinds Trump Administration Insulin Pricing Rule
One of the final healthcare actions made by the Trump Administration has been rescinded by the Biden Administration. On December 23, 2020, the Trump Administration finalized a rule that directed the Department of Health and Human Services (HHS) to ta
www.policymed.com
(CNN)A freeze by the new Biden administration on Trump-era regulations will hit at least two rules aimed at lowering drug prices, including one dealing with insulin and EpiPens for under-served patients.
Biden freeze hits two Trump drug price rules | CNN Politics
A freeze by the new Biden administration on Trump-era regulations will hit at least two rules aimed at lowering drug prices, including one dealing with insulin and EpiPens for under-served patients.
www.cnn.com
June 17, 2021
Biden administration proposes rescinding rule on community health center insulin discounts
The Biden administration proposed rescinding a final rule introduced under the Trump administration that would require community health centers to pass on 340B drug discounts for insulin and injectable epinephrine to low-income patients.
In July 2020, President Donald Trump signed four executive orders aimed at reining in prescription drug costs. One required that federally qualified health centers, which purchase insulin and epinephrine through what's called the 340B drug program, pass along any savings they receive from discounted drug prices to medically underserved patients.
The rule blocks health centers from receiving future federal grants unless they charge patients no more than their acquisition price for insulin and EpiPens — epinephrine auto-injectors — plus a small administration fee.
TODAY: BIDEN ANNOUNCES PRICE REDUCTION PUSH- FOCUSING HEAVILY ON INSULIN
Biden to push Build Back Better Act, focusing on its prescription drug provisions
President Joe Biden on Monday will highlight provisions to lower the prices of prescription drugs in the Build Back Better Act as his signature legislation awaits Senate action.
www.cnn.com